vs

Side-by-side financial comparison of KKR Real Estate Finance Trust Inc. (KREF) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $25.8M, roughly 1.9× KKR Real Estate Finance Trust Inc.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -101.7%, a 30.2% gap on every dollar of revenue. On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -26.6%). Over the past eight quarters, MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue compounded faster (-11.9% CAGR vs -18.8%).

KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

KREF vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.9× larger
MRVI
$49.9M
$25.8M
KREF
Growing faster (revenue YoY)
MRVI
MRVI
+14.8% gap
MRVI
-11.8%
-26.6%
KREF
Higher net margin
MRVI
MRVI
30.2% more per $
MRVI
-71.6%
-101.7%
KREF
Faster 2-yr revenue CAGR
MRVI
MRVI
Annualised
MRVI
-11.9%
-18.8%
KREF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KREF
KREF
MRVI
MRVI
Revenue
$25.8M
$49.9M
Net Profit
$-26.2M
$-35.7M
Gross Margin
25.8%
Operating Margin
-105.1%
-117.9%
Net Margin
-101.7%
-71.6%
Revenue YoY
-26.6%
-11.8%
Net Profit YoY
-229.6%
-37.7%
EPS (diluted)
$-0.49
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KREF
KREF
MRVI
MRVI
Q4 25
$25.8M
$49.9M
Q3 25
$25.3M
$41.6M
Q2 25
$30.2M
$47.4M
Q1 25
$31.3M
$46.9M
Q4 24
$35.1M
$56.6M
Q3 24
$37.0M
$69.0M
Q2 24
$40.4M
$69.4M
Q1 24
$39.1M
$64.2M
Net Profit
KREF
KREF
MRVI
MRVI
Q4 25
$-26.2M
$-35.7M
Q3 25
$13.8M
$-25.6M
Q2 25
$-29.7M
$-39.6M
Q1 25
$-4.9M
$-29.9M
Q4 24
$20.3M
$-25.9M
Q3 24
$-7.4M
$-97.1M
Q2 24
$25.8M
$-9.8M
Q1 24
$-3.1M
$-12.1M
Gross Margin
KREF
KREF
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
KREF
KREF
MRVI
MRVI
Q4 25
-105.1%
-117.9%
Q3 25
50.4%
-98.6%
Q2 25
-101.3%
-139.8%
Q1 25
-18.3%
-104.9%
Q4 24
55.8%
-66.7%
Q3 24
-19.6%
-239.9%
Q2 24
63.3%
-19.4%
Q1 24
-8.7%
-29.4%
Net Margin
KREF
KREF
MRVI
MRVI
Q4 25
-101.7%
-71.6%
Q3 25
54.4%
-61.4%
Q2 25
-98.5%
-83.5%
Q1 25
-15.5%
-63.9%
Q4 24
57.7%
-45.8%
Q3 24
-20.0%
-140.6%
Q2 24
63.9%
-14.1%
Q1 24
-7.9%
-18.8%
EPS (diluted)
KREF
KREF
MRVI
MRVI
Q4 25
$-0.49
$-0.24
Q3 25
$0.12
$-0.18
Q2 25
$-0.53
$-0.27
Q1 25
$-0.15
$-0.21
Q4 24
$0.22
$-0.21
Q3 24
$-0.19
$-0.68
Q2 24
$0.29
$-0.07
Q1 24
$-0.13
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KREF
KREF
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$84.6M
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$1.2B
$212.4M
Total Assets
$6.5B
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KREF
KREF
MRVI
MRVI
Q4 25
$84.6M
$216.9M
Q3 25
$204.1M
$243.6M
Q2 25
$107.7M
$269.9M
Q1 25
$106.4M
$285.1M
Q4 24
$104.9M
$322.4M
Q3 24
$108.8M
$578.2M
Q2 24
$107.2M
$573.2M
Q1 24
$106.5M
$561.7M
Total Debt
KREF
KREF
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
KREF
KREF
MRVI
MRVI
Q4 25
$1.2B
$212.4M
Q3 25
$1.2B
$245.4M
Q2 25
$1.2B
$265.9M
Q1 25
$1.3B
$300.6M
Q4 24
$1.3B
$325.3M
Q3 24
$1.4B
$344.9M
Q2 24
$1.4B
$434.7M
Q1 24
$1.4B
$410.7M
Total Assets
KREF
KREF
MRVI
MRVI
Q4 25
$6.5B
$770.6M
Q3 25
$6.5B
$849.2M
Q2 25
$6.8B
$897.0M
Q1 25
$6.6B
$959.8M
Q4 24
$6.4B
$1.0B
Q3 24
$6.8B
$1.3B
Q2 24
$7.1B
$1.4B
Q1 24
$7.3B
$1.4B
Debt / Equity
KREF
KREF
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KREF
KREF
MRVI
MRVI
Operating Cash FlowLast quarter
$72.3M
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KREF
KREF
MRVI
MRVI
Q4 25
$72.3M
$-22.8M
Q3 25
$18.5M
$-15.2M
Q2 25
$21.1M
$-10.3M
Q1 25
$15.9M
$-9.4M
Q4 24
$132.6M
$-14.6M
Q3 24
$49.1M
$13.1M
Q2 24
$30.6M
$17.4M
Q1 24
$34.5M
$-8.5M
Free Cash Flow
KREF
KREF
MRVI
MRVI
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
KREF
KREF
MRVI
MRVI
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
KREF
KREF
MRVI
MRVI
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
KREF
KREF
MRVI
MRVI
Q4 25
Q3 25
1.34×
Q2 25
Q1 25
Q4 24
6.54×
Q3 24
Q2 24
1.19×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KREF
KREF

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons